Peroxisome proliferators reduce spatial memory impairment, synaptic failure, and neurodegeneration in brains of a double transgenic mice model of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 33, Issue 4, 2013, Pages 941-959

  Inestrosa, Nibaldo C ^a,b,c   Carvajal, Francisco J ^a   Zolezzi, Juan M ^a   Tapia Rojas, Cheril ^a   Serrano, Felipe ^a   Karmelic, Daniel ^a   Toro, Andrés ^b   Toro, Jessica ^b   Santos, Manuel J ^b  

^a Centro de Envejecimiento y Regeneración CARE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Amyloid peptide; peroxisomal proliferation; spatial memory; synaptic plasticity; transgenic mice

Indexed keywords

4 PHENYLBUTYRIC ACID; ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; CD11B ANTIGEN; PIRINIXIC ACID; POSTSYNAPTIC DENSITY PROTEIN 95; PRESENILIN 1; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXON; GLIOSIS; HIPPOCAMPUS; IN VIVO STUDY; LONG TERM POTENTIATION; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; MOUSE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SPATIAL MEMORY;

EID: 84873625462     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120397     Document Type: Article

References (78)

1. Giordano RC, Terlecky SR (2012) Peroxisomes, cell senescence, and rates of aging. Biochim Biophys Acta 1822, 1358-1362
2. Inestrosa NC, Bronfman M, Leighton F (1979) Detection of peroxisomal fatty acyl-coenzymeAoxidase activity. Biochem J 182, 779-788
3. Lazarow PB (2003) Peroxisome biogenesis: Advances and conundrums. Curr Opin Cell Biol 15, 489-497
4. Santos MJ, Ojeda JM, Garrido J, Leighton F (1985) Peroxisomal organization in normal and cerebrohepatorenal (Zellweger) syndrome fibroblasts. Proc Natl Acad Sci U S A 82, 6556-6560
5. Ishikawa T, Kawai C, Sano M, Minatogawa Y (2001) Peroxisomes exist in growth cones and move anterogradely and retrogradely in neurites of PC12D cells. Exp Cell Res 266, 260-269
6. Hulshagen L, Krysko O, Bottelbergs A, Huyghe S, Klein R, Van Veldhoven PP, De Deyn PP, D'Hooge R, Hartmann D, Baes M (2008) Absence of functional peroxisomes from mouse CNS causes dysmyelination and axon degeneration. J Neurosci 28, 4015-4027
7. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156, 1051-1063
8. Berger J, Moller DE (2002) The mechanisms of action of PPARs. Annu Rev Med 53, 409-435
9. Corton JC, Anderson SP, Stauber A (2000) Central role of peroxisome proliferator-Activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol 40, 491-518
10. Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G, Buendia MA (2000) Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 19, 498-504
11. Liu N, Qiang W, Kuang X, Thuillier P, Lynn WS, Wong PK (2002) The peroxisome proliferator phenylbutyric acid (PBA) protects astrocytes from ts1 MoMuLV-induced oxidative cell death. J Neurovirol 8, 318-325
12. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer's disease. Lancet 377, 1019-1031
13. Selkoe DJ (2011) Resolving controversies on the path to Alzheimer's therapeutics. Nat Med 17, 1060-1065
14. Lee HP, Zhu X, Casadesus G, Castellani RJ, Nunomura A, Smith MA, Lee HG, Perry G (2010) Antioxidant approaches for the treatment of Alzheimer's disease. Expert Rev Neurother 10, 1201-1208
15. Miranda S, Opazo C, Larrondo LF, Munoz FJ, Ruiz F, Leighton F, InestrosaNC(2000) The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease. Prog Neurobiol 62, 633-648
16. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121
17. Abramov AY, Canevari L, Duchen MR (2004) {beta}-Amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 24, 565-575
18. Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817-827
19. Habib LK, Lee MT, Yang J (2010) Inhibitors of catalaseamyloid interactions protect cells from beta-Amyloid-induced oxidative stress and toxicity. J Biol Chem 285, 38833-38843
20. Nishida Y, Ito S, Ohtsuki S, Yamamoto N, Takahashi T, Iwata N, Jishage K, Yamada H, Sasaguri H, Yokota S, Piao W, Tomimitsu H, Saido TC, Yanagisawa K, Terasaki T, Mizusawa H, Yokota T (2009) Depletion of vitamin E increases amyloid beta accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease. J Biol Chem 284, 33400-33408
21. Bonnefort AB, Munoz FJ, Inestrosa NC (1998) Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-Amyloid complexes. FEBS Lett 441, 220-224
22. Goodman Y, Bruce AJ, Cheng B, Mattson MP (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 66, 1836-1844
23. Quintanilla RA, Munoz FJ, Metcalfe MJ, Hitschfeld M, Olivares G, Godoy JA, Inestrosa NC (2005) Trolox and 17beta-estradiol protect against amyloid beta-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. J Biol Chem 280, 11615-11625
24. Dumont M, Beal MF (2011) Neuroprotective strategies involving ROS in Alzheimer's disease. Free Radic Biol Med 51, 1014-1026
25. Pappolla MA, Sos M, Omar RA, Bick RJ, Hickson-Bick DL, Reiter RJ, Efthimiopoulos S, Robakis NK (1997) Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci 17, 1683-1690
26. Cimini A, Benedetti E, D'Angelo B, Cristiano L, Falone S, Di Loreto S, Amicarelli F, Cer̀uMP (2009) Neuronal response of peroxisomal and peroxisome-related proteins to chronic and acute Abeta injury. Curr Alzheimer Res 6, 238-251
27. Santos MJ, Quintanilla RA, Toro A, Grandy R, Dinamarca MC, Godoy JA, Inestrosa NC (2005) Peroxisomal proliferation protects from beta-Amyloid neurodegeneration. J Biol Chem 280, 41057-41068
28. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-Amyloid peptide in vivo: Evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13, 159-170
29. Santos MJ, Imanaka T, Shio H, Lazarow PB (1988) Peroxisomal integral membrane proteins in control and Zellweger fibroblasts. J Biol Chem 263, 10502-10509
30. De Ferrari GV, Chacon MA, Barria MI, Garrido JL, Godoy JA, Olivares G, Reyes AE, Alvarez A, Bronfman M, Inestrosa NC (2003) Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-Amyloid fibrils. Mol Psychiatry 8, 195-208
31. Toledo EM, Inestrosa NC (2010) Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease. Mol Psychiatry 15, 272-285
32. Besheer J, Short KR, Bevins RA (2001) Dopaminergic and cholinergic antagonism in a novel-object detection task with rats. Behav Brain Res 126, 211-217
33. Tago H, Kimura H, Maeda T (1986) Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical procedure. J Histochem Cytochem 34, 1431-1438
34. Carvajal FJ, Inestrosa NC (2011) Interactions of AChE with A aggregatess in Alzheimer's brain: Therapeutic relevance of IDN 5706. Front Molec Neurobiol 4, 1-10
35. Reyes AE, Chacon MA, Dinamarca MC, CerpaW, Morgan C, Inestrosa NC (2004) Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: Effect on rat beta-Amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss. Am J Pathol 164, 2163-2174
36. Chacon MA, Barria MI, Soto C, Inestrosa NC (2004) -sheet breaker peptide prevents A-induced spatial memory impairments with partial reduction of amyloid deposits. Mol Psychiatry 9, 953-961
37. Cutiño L, Godoy JA, Farias GG, CouveA, Bonansco C, Fuenzalida M, Inestrosa NC (2010) Wnt-A modulates recycling of functional GABAA receptors on hippocampal neurons. J Neurosci 30, 8411-8420
38. Cerpa W, Godoy JA, Alfaro I, Farias GG, Metcalfe MJ, Fuentealba R, Bonansco C, InestrosaNC(2008) Wnt-7a modulates the synaptic vesicle cycle and synapitc transmission in hippocampal neurons. J Biol Chem 283, 5918-5927
39. Cerpa W, Farias GG, Godoy JA, Fuenzalida M, Bonansco C, Inestrosa NC (2010) Wnt-5a occludes A oligomer-induced depression of glutamatergic transmission in hippocampal neurons. Mol Neurodegener 5, 3
40. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, FroschMP(2006) Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24, 516-524
41. Morris RG, Garrud P, Rawlins JN, O'Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297, 681-683
42. Bussìere T, Bard F, Barbour R, Grajeda H, Guido T, Khan K, Schenk D, Games D, Seubert P, Buttini M (2004) Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance. Am J Pathol 165, 987-995
43. Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J (1996) Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme. Neuron 16, 881-891
44. Dinamarca MC, Sagal JP, Quintanilla RA, Godoy JA, Arrazola MS, Inestrosa NC (2010) Amyloid-betaacetylcholinesterase complexes potentiate neurodegenerative changes induced by the Abeta peptide. Implications for the pathogenesis of Alzheimer's disease. Mol Neurodegener 5, 4
45. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, StreitW, Strohmeyer R, Tooyoma I, VanMuiswinkel FL,Veerhuis R,Walker D,Webster S,Wegrzyniak B,Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21, 383-421
46. Inestrosa NC, Toledo EM (2008) The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease. Mol Neurodegener 3, 9
47. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580
48. Boeckers TM (2006) The postsynaptic density. Cell Tissue Res 326, 409-422
49. Santos MS, Li H, SMV (2009) Synaptic vesicle protein trafficking at the glutamate synapse. Neuroscience 158, 189-203
50. Whitlock JR, Heynen AJ, Shuler MG, Bear MF (2006) Learning induces long-Term potentiation in the hippocampus. Science 313, 1093-1097
51. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21, 8370-8377
52. Lovell MA, Ehmann WD, Butler SM, MarkesberyWR(1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601
53. Gray E, Ginty M,Kemp K, Scolding N,WilkinsA(2012) The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function. J Neuroinflammation 9, 63
54. Gondcaille C, Depreter M, Fourcade S, Lecca MR, Leclercq S, Martin PG, Pineau T, Cadepond F, ElEtr M, Bertrand N, Beley A, Duclos S, De Craemer D, Roels F, Savary S, Bugaut M (2005) Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator. J Cell Biol 169, 93-104
55. Romieu P, Host L, Gobaille S, Sandner G, Aunis D, Zwiller J (2008) Histone deacetylase inhibitors decrease cocaine but not sucrose self-Administration in rats. J Neurosci 28, 9342-9348
56. Peleg S, Sananbenesi F, Zovoilis A, Burkhardt S, Bahari-Javan S, Agis.Balboa RC, Cota P,Wittnam JL, Gogol-Doering A, Opitz L, Salinas-Riester G, Dettenhofer M, Kang H, Farinelli L, ChenW, Fischer A, (2010) Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328, 753-756
57. Ricobaraza A, Cuadrado-Tejedor M, Perez-Mediavilla A, Frechilla D, Del Rio J, Garćia-Osta A (2009) Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology 34, 1721-1732
58. Li X, Baumgart E, Dong GX, Morrell JC, Jimenez-Sanchez G, Valle D, Smith KD, Gould SJ (2002) PEX11alpha is required for peroxisome proliferation in response to 4-phenylbutyrate but is dispensable for peroxisome proliferator-Activated receptor alpha-mediated peroxisome proliferation. Mol Cell Biol 22, 8226-8240
59. Collino M, Aragno M, Mastrocola R, Benetti E, Gallicchio M, Dianzani C, Danni O, Thiemermann C, Fantozzi R (2006) Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: Effects of PPAR-Agonist WY 14643. Free Radic Biol Med 41, 579-589
60. Shi Q, Gibson GE (2007) Oxidative stress and transcriptional regulation in Alzheimer's disease. Alzheimer Dis Assoc Disord 21, 276-291
61. Chen YC,Wu JS, Tsai HD, Huang CY, Chen JJ, Sun GY, Lin TN (2012) Peroxisome proliferator-Activated receptor gamma (PPAR-) and neurodegenerative disorders. Mol Neurobiol 46, 114-124
62. Scuderi C, Valenza M, Stecca C, Esposito G, Carrat̀u MR, Steardo L (2012) Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator- Activated receptor-. J Neuroinflammation 9, 49
63. Akiyama H, McGeerPL(1990) Brain microglia constitutively express beta-2 integrins. J Neuroimmunol 30, 81-93
64. Chawla A, Boisvert WA, Lee C, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM, Tontonoz P (2001) A PPAR-LRX-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 7, 161-171
65. Mandrekar-Colucci S, Karlo JC, Landreth GE (2012) Mechanisms underlying the rapid peroxisome proliferator-Activated receptor-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. J Neurosci 32, 10117-10128
66. Cramer PE, Cirrito JR, Wesson DW, Daniel Lee CY, Karlo C, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden JK,Wilson DA, Landreth GE (2012) ApoE-directed therapeutics rapidly clear -Amyloid and reverse deficit inAD mouse models. Science 335, 1503-1506
67. Biserni A, Giannessi F, Sciarroni AF, Milazzo FM, Maggi A, Ciana P (2008) In vivo imaging reveals selective per oxisome preoliferator activated receptor modulator activity of the synthetic ligand 3-(1-(4-Chlorobenzyl)-2-T-butylthio- 5-isopropylindol-2-yl)-2,2-dimethylpropanoic acid (MK-886). Mol Pharmacol 73, 1434-1443
68. Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12, 723-738
69. Dalkara T, Gursoy-Ozdemir Y, Yemisci M (2011) Brain microvascular pericytes in health and disease. Acta Neuropathol 122, 1-9
70. Hoque Md. T, Robillard KR, Bendayan R, (2012) Regulation of breast cancer resistant protein by peroxisome proliferatoractivated receptor in human brain microvessel endothelial cells. Mol Pharmacol 81, 598-609
71. Castellani RJ, Nunomura A, Lee HG, Perry G, Smith MA (2008) Phosphorylated tau: Toxic, protective, or none of above. J Alzheimers Dis 14, 377-383
72. Bonda DJ, Castellani RJ, Zhu X, Nunomura A, Lee HG, Perry G, Smith MA (2011) A novel perspective on tau in Alzheimer's disease. Curr Alzheimer Res 8, 639-642
73. Ballatore C, Lee VM, Trojanowski JG (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8, 663-672
74. Lynch MA (2004) Long-Term potentiation and memory. Physiol Rev 84, 87-136
75. Leung LS (2009) Kindling, long-Term potentiation and spatial memory performance. Can J Neurol Sci 36(SUPPL2), S36-S38
76. Schapiro ML, Eichenbaum H (1999) Hippocampus as memory map: Synaptic plasicity and memory encoding by hippocampal neurons. Hippocampus 9, 365-384
77. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791
78. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer's disease. Cold Spring Harb Perspect Med 1, a006189